[ad_1]
103 people went into recovery on the last day. Last day 3,923 molecular tests (PCR) and 197 antigens were carried out in the country on suspicion of coronavirus.
The rate of new illnesses in the last 14 days is 100,000. the population reaches 222.9 cases. The proportion of positive diagnostic tests in the last seven days is 6.4 percent.
A total of 204,356 people have become ill with COVID-19 in Lithuania since the start of the pandemic.
Statistically recovered and currently 190,234 people are alive, 146,141 declared recovered. Statistically, there are currently 6827 sick people, the declared number of patients is 50 920.
The Department of Statistics considers that a person declared sick has a confirmed case and the end of the disease has not been confirmed by a doctor. A statistically ill person is one for whom illness has been confirmed in the last 28 days. After this period, the person is considered statistically healthy.
According to the department, the statistical rate of patients may be more accurate to assess the morbidity of the population, since among declared patients there may be cases in which a person is no longer ill but the GP has not confirmed the end of the illness. .
A total of 3,373 people died in Lithuania from COVID-19. 6,801 deaths have been associated, directly and indirectly, with this infectious disease.
The first dose of COVID-19 was administered to 417 people last day and the second to 674 people. A total of 241,746 people were vaccinated with the first dose in the country and 91,546 people with both doses.
Hospitals are currently treating 857 COVID-19 patients, 90 of whom are in resuscitation.
Lithuanian hospitals are currently treating 857 COVID-19 patients, 90 of them in resuscitation, Statistics Lithuania reported on Friday.
Oxygen is added to 723 patients and 56 patients receive artificial lung ventilation.
73 people were hospitalized for COVID-19 per day.
On March 11, the festive atmosphere in Lithuania was somewhat distracted by the signs over Norway, Denmark and Iceland: these countries announced that they were temporarily suspending vaccination with the AstraZeneca vaccine. Lithuania has also discontinued a batch of this vaccine. However, the decision of the European Medicines Agency (EMA) to approve the Johnson & Johnson vaccine, which is sufficient for a single vaccine, has resonated.
There were concerns about the AstraZeneca vaccine
The Danes were the first to announce the decision on Thursday. They decided to find out if there was a link between blood clots found in various people who had been vaccinated and the AstraZeneca vaccine. Norway made that decision early and then Iceland announced it.
The EVA was quick to appease passions: it announced that the risk of blood clots is probably “not higher.”
“Currently, the available information suggests that the number of thromboembolic events among vaccinated people is not higher than in the general population,” said the EVA.
Denmark is said to have made the decision as a precautionary measure.
Talked about the problem
Rolanda Lingienė, head of the Vilnius Department of the National Center for Public Health (NVSC), spoke about an unsolvable problem.
She announced that more than 40 percent. The circumstances of the contagion cases confirmed in Vilnius in February are unknown, but this is not the fault of the specialists, but the consequences of people’s behavior.
“Why? Definitely not because we couldn’t. The reasons are very simple and have been talked about more than once: either there were no phone numbers of the people on e-health or they were wrong. A small part has not yet I was ready to cooperate, “R. Lingienė wrote on Facebook on Thursday evening.
